Study of the Efficacy and Safety of AMT-101 in Combination With Adalimumab in Subjects With Ulcerative Colitis (MARKET)
Condition: Ulcerative Colitis Interventions: Drug: AMT-101 (oral); Other: Placebo (oral); Combination Product: Humira (adalimumab) Sponsor: Applied Molecular Transport Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials